Toncoin-focused treasury company AlphaTON agrees to sell cancer treatment subsidiary https://t.co/RXMwKSyoKV ...

Core Insights - Janux Therapeutics has announced a collaboration with Bristol Myers Squibb to develop a new cancer treatment, which has resulted in a more than 12% increase in its shares during premarket trading [1] Company Summary - Janux Therapeutics is engaging in a partnership with Bristol Myers Squibb aimed at advancing a new cancer therapy [1] - The announcement of this collaboration has positively impacted Janux Therapeutics' stock performance, reflecting investor optimism [1]

Industry Overview - The "cancer-industrial complex" generates billions of dollars for drug companies [1] - Cancer treatments often fail to extend patients' lives [1] Business Focus - The report explores the big business of cancer treatment [1]

Industry Overview - The "cancer-industrial complex" generates billions of dollars for drug companies [1] - Cancer treatments often fail to extend patients' lives [1] Business Focus - The report explores the big business of cancer treatment [1]

Industry Overview - The "cancer-industrial complex" generates billions of dollars for drug companies [1] - Cancer treatments often fail to extend patients' lives [1] Business Focus - The report explores the big business of cancer treatment [1]